Cite
Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome.
MLA
Ma, Shaokang, et al. “Pre-Treatment Tumor Neo-Antigen Responses in Draining Lymph Nodes Are Infrequent but Predict Checkpoint Blockade Therapy Outcome.” OncoImmunology, vol. 9, no. 1, Jan. 2020, pp. 1–11. EBSCOhost, https://doi.org/10.1080/2162402X.2019.1684714.
APA
Ma, S., Chee, J., Fear, V. S., Forbes, C. A., Boon, L., Dick, I. M., Robinson, B. W. S., & Creaney, J. (2020). Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome. OncoImmunology, 9(1), 1–11. https://doi.org/10.1080/2162402X.2019.1684714
Chicago
Ma, Shaokang, Jonathan Chee, Vanessa S. Fear, Catherine A. Forbes, Louis Boon, Ian M. Dick, Bruce W. S. Robinson, and Jenette Creaney. 2020. “Pre-Treatment Tumor Neo-Antigen Responses in Draining Lymph Nodes Are Infrequent but Predict Checkpoint Blockade Therapy Outcome.” OncoImmunology 9 (1): 1–11. doi:10.1080/2162402X.2019.1684714.